Dorota is an experienced executive leader in the biopharmaceutical industry, with a successful track record across multiple disease areas. Throughout her career, she has focused on solving complex challenges that arise where healthcare meets real-world needs – with a commitment to helping people and families facing difficult-to-manage diseases. Prior to her appointment as COO of the Foundation in 2025, Dorota served in prominent roles, such as Regional Lead for the BeNeLux and Central and Eastern European region at Biogen.
Her consistent success in driving strategy and operational excellence has proven Dorota’s ability to lead transformational growth at both country and regional and levels. She has successfully led international product launches, strengthened regional capabilities, managed performance across diverse markets, and held full profit and loss (P&L) responsibility at the local level. Dorota’s leadership experience has seen her build effective teams and cultivate strong partnerships that have been steered by a clear focus on meaningful impact.